Literature DB >> 4555882

A double-blind comparison of sulpiride with chlorpromazine in chronic schizophrenia.

M Toru, Y Shimazono, M Miyasaka, T Kokubo, Y Mori, T Nasu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4555882     DOI： 10.1002/j.1552-4604.1972.tb00166.x

Source DB:  PubMed          Journal:  J Clin Pharmacol New Drugs        ISSN： 0021-9754


× No keyword cloud information.
  10 in total

1.  A clinical and pharmacodynamic evaluation of sulpiride.

Authors:  V A Rao; J Bailey; M Bishop; A Coppen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

2.  Effect of sulpiride on monoaminergic mechanisms in psychotic women.

Authors:  L Bjerkenstedt; C Härnryd; G Sedval
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

Review 3.  A risk-benefit assessment of sulpiride in the treatment of schizophrenia.

Authors:  M C Mauri; S Bravin; A Bitetto; R Rudelli; G Invernizzi
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

4.  Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.

Authors:  S Usuda; K Nishikori; O Noshiro; H Maeno
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Sulpiride trial in chronic schizophrenia with comparison of two dosage regimens.

Authors:  D M Lewis; H R Bond; S H Curry
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.

Authors:  G Alfredsson; C Härnryd; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations.

Authors:  F A Wiesel; G Alfredsson; M Ehrnebo; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.

Authors:  F A Wiesel; G Alfredsson; M Ehrnebo; G Sedvall
Journal:  Eur J Clin Pharmacol       Date:  1980-05       Impact factor: 2.953

9.  An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET.

Authors:  L Farde; F A Wiesel; P Jansson; G Uppfeldt; A Wahlen; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment.

Authors:  G Alfredsson; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.